Advanced search
Publication Cover
International Journal of General Medicine Volume 17, 2024 - Issue
Submit an article Journal homepage
155
Views
0
CrossRef citations to date
0
Altmetric
General Medicine

Combining Traditional Chinese Herbs and csDMARDs for the Treatment of Rheumatoid Arthritis Involves Tapering and Discontinuing Glucocorticoids: Protocol for a Two-Stage Non-Randomized Controlled Trial

Xingqiang Wang1 Department of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of China;2 Yunnan Provincial Clinical Medicine Research Center of Rheumatism in TCM, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-0241-7809View further author information
ORCID Icon,
Xianna Yang3 The First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Shiqi Wang3 The First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Xiaofang Tian1 Department of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Jianmei Yin3 The First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Nian Liu3 The First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Pengtao Di1 Department of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Jipeng Qi3 The First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Ya Li3 The First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Jimin Chen3 The First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of China;4 Department of Integrative Internal Medicine, The Lijiang Hospital of Traditional Chinese Medicine, Lijiang, Yunnan, 674100, People’s Republic of ChinaView further author information
,
Yang Wu1 Department of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Jingjin Wu1 Department of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of China;2 Yunnan Provincial Clinical Medicine Research Center of Rheumatism in TCM, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Weiqing Zhao5 Department of Rheumatology and Immunology, The First People’s Hospital of Yunnan Province and The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, 650034, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7957-6560View further author information
ORCID Icon,
Jiangyun Peng1 Department of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of China;2 Yunnan Provincial Clinical Medicine Research Center of Rheumatism in TCM, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
,
Ling Zhang1 Department of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of China;2 Yunnan Provincial Clinical Medicine Research Center of Rheumatism in TCM, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
&
Lingli Gu1 Department of Rheumatology, The No. 1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650021, People’s Republic of ChinaView further author information
 show all
Pages 827-839 | Received 10 Oct 2023, Accepted 10 Feb 2024, Published online: 05 Mar 2024

References

  • Hardy R, Cooper MS. Unravelling how glucocorticoids work in rheumatoid arthritis. Nat Rev Rheumatol. 2018;14(10):566–567. doi:10.1038/s41584-018-0079-4
  • Chinese Rheumatology Association. 2018 Chinese guideline for the diagnosis and treatment of rheumatoid arthritis. Zhonghua Nei Ke Za Zhi. 2018;57(4):242–251. doi:10.3760/cma.j.issn.0578-1426.2018.04.004
  • Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheumatic Dis. 2020;79(6):685–699. doi:10.1136/annrheumdis-2019-216655
  • Burmester GR, Buttgereit F, Bernasconi C, et al. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial. Lancet. 2020;396(10246):267–276. doi:10.1016/S0140-6736(20)30636-X
  • Singh JA, Saag KG, Bridges SL, et al. 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68(1):1–26. doi:10.1002/art.39480
  • Roubille C, Coffy A, Rincheval N, et al. Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early rheumatoid arthritis. Rheumatology. 2021;60(8):3738–3746. doi:10.1093/rheumatology/keaa850
  • Fraenkel L, Bathon JM, England BR, et al. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2021;73(7):1108–1123. doi:10.1002/art.41752
  • van Ouwerkerk L, Palmowski A, Nevins IS, et al. Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Ann Rheumatic Dis. 2022;81(7):937–943. doi:10.1136/annrheumdis-2022-222338
  • Xie W, Huang H, Li G, et al. Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020. Ann Rheumatic Dis. 2021;80(8):997–1003. doi:10.1136/annrheumdis-2021-220112
  • Zhang D, Lyu JT, Zhang B, Zhang XM, Jiang H, Lin ZJ. Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis. BMC Complement Med Therap. 2020;20(1):210. doi:10.1186/s12906-020-03004-4
  • Wang Y, Han M, Pedigo CE, Xie ZM, Wang WJ, Liu JP. Chinese herbal medicine for systemic lupus erythematosus: a systematic review and meta-analysis of randomized, placebo-controlled trials. Chin J Integr Med. 2021;27(10):778–787. doi:10.1007/s11655-021-3497-0
  • Zhu H, Zhang L, Qian M, et al. Microgravity versus microgravity and irradiation: investigating the change of neuroendocrine-immune system and the antagonistic effect of traditional Chinese medicine formula. Biomed Res Int. 2020;2020:2641324. doi:10.1155/2020/2641324
  • Huang J, Li J, Zheng S, et al. Epimedium flavonoids counteract the side effects of glucocorticoids on hypothalamic-pituitary-adrenal axis. Evid Based Complement Alternat Med. 2013;2013:938425. doi:10.1155/2013/938425
  • Qin F, Wu J, Chen F, et al. Optimal, minimax and admissible two-stage design for phase II oncology clinical trials. BMC Med. Res. Method. 2020;20(1):126. doi:10.1186/s12874-020-01017-8
  • van Ouwerkerk L, Boers M, Emery P, et al. Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Ann Rheumatic Dis. 2022;82(4):468–475. doi:10.1136/ard-2022-223443
  • Cutolo M, Sulli A, Pincus T. Circadian use of glucocorticoids in rheumatoid arthritis. Neuroimmunomodulation. 2015;22(1–2):33–39. doi:10.1159/000362733
  • Alves C, Robazzi TC, Mendonca M. Withdrawal from glucocorticosteroid therapy: clinical practice recommendations. J Paediatr. 2008;84(3):192–202. doi:10.2223/JPED.1773
  • Smolen JS, Breedveld FC, Eberl G, et al. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum. 1995;38(1):38–43. doi:10.1002/art.1780380106
  • Qian XB, Chen T, Xu, YP et al. A guide to human microbiome research: study design, sample collection, and bioinformatics analysis. Chin Med J. 2020;133:1844–1855— doi:10.1097/CM9.0000000000000871.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.